Cost-effectiveness of liposomal amphotericin B in hospitalised patients with mucocutaneous leishmaniasis

Social and Economic Burden of Human Leishmaniasis

(2016) Ifeoma Okwor et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Liposomal Amphotericin B drug access for the treatment of leishmaniasis in Brazil

(2016) Sostenes Mistro et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Nephrotoxicity and other adverse events among inpatients receiving liposomal amphotericin B or amphotericin B lipid complex

(2013) Rolin L. Wade et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Liposomal amphotericin B in comparison to sodium stibogluconate for Leishmania braziliensis cutaneous leishmaniasis in travelers

(2012) Michal Solomon et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Randomized Controlled Clinical Trial to Access Efficacy and Safety of Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

(2011) Anette Chrusciak-Talhari et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India

(2010) Shyam Sundar et al.   NEW ENGLAND JOURNAL OF MEDICINE

Miltefosine in the Treatment of Cutaneous Leishmaniasis Caused by Leishmania braziliensis in Brazil: A Randomized and Controlled Trial

(2010) Paulo R. Machado et al.   PLoS Neglected Tropical Diseases

Treatment of New World cutaneous leishmaniasis - a systematic review with a meta-analysis

(2009) Felipe Francisco Tuon et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Drug regimens for visceral leishmaniasis in Mediterranean countries

(2008) Luigi Gradoni et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH